 |
Subscribe / Renew |
 |
Contact Us |
| ► Subscribe to our Free Weekly Newsletter | |
Construction Bids
| home | Welcome, sign in or click here to subscribe. | login |
Business
 print  email to a friend  reprints add to mydjc |  |
July 21, 2004
Dendreon
Biotechnology company Dendreon Corp. appointed Linda Staley vice president of information technology. Staley will lead strategic planning to commercialize Provenge, the company's therapeutic cancer vaccine. Staley was an executive director at Cardinal Health's nuclear pharmacy division. Seattle-based Dendreon works on therapies for cancer.